Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
2003 1
2012 1
2013 1
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis.
Horsfield MA, Barker GJ, Barkhof F, Miller DH, Thompson AJ, Filippi M. Horsfield MA, et al. J Magn Reson Imaging. 2003 Apr;17(4):389-97. doi: 10.1002/jmri.10266. J Magn Reson Imaging. 2003. PMID: 12655577
Quantitative evaluation of brain magnetic resonance imaging (MRI) scans is now an accepted part of the trial of new putative treatments for multiple sclerosis (MS). ...Magnetization transfer (MT) imaging is a r
Quantitative evaluation of brain magnetic resonance imaging (MRI) scans is now an accepted part of the trial of
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis.
Filippi M, Horsfield MA, Adèr HJ, Barkhof F, Bruzzi P, Evans A, Frank JA, Grossman RI, McFarland HF, Molyneux P, Paty DW, Simon J, Tofts PS, Wolinsky JS, Miller DH. Filippi M, et al. Ann Neurol. 1998 Apr;43(4):499-506. doi: 10.1002/ana.410430414. Ann Neurol. 1998. PMID: 9546332
The change of brain lesion load, measured on T2-weighted magnetic resonance imaging (MRI) using computer-assisted techniques, is a widely used secondary endpoint for phase III clinical trials in multiple sclerosis (MS). ...This review considers …
The change of brain lesion load, measured on T2-weighted magnetic resonance imaging (MRI) using computer-assisted techn …
Quantitative measures of walking and strength provide insight into brain corticospinal tract pathology in multiple sclerosis.
Fritz NE, Keller J, Calabresi PA, Zackowski KM. Fritz NE, et al. Neuroimage Clin. 2017 Feb 20;14:490-498. doi: 10.1016/j.nicl.2017.02.006. eCollection 2017. Neuroimage Clin. 2017. PMID: 28289599 Free PMC article.
However, the relationship between walking performance and brain corticospinal tract magnetization transfer imaging measures and the contribution of clinical measurements of walking and strength to the underlying integrity of the corticospinal tract has not be …
However, the relationship between walking performance and brain corticospinal tract magnetization transfer imaging meas …
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC, Simon J. Miller DH, et al. Ann Neurol. 1996 Jan;39(1):6-16. doi: 10.1002/ana.410390104. Ann Neurol. 1996. PMID: 8572668
Because of the major difficulties in measuring clinical end points in multiple sclerosis (MS) treatment trials, there has been much enthusiasm for using magnetic resonance imaging (MRI) findings as an alternative outcome. ...Putative m
Because of the major difficulties in measuring clinical end points in multiple sclerosis (MS) treatment trials, there h …
Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma.
Jamin Y, Tucker ER, Poon E, Popov S, Vaughan L, Boult JK, Webber H, Hallsworth A, Baker LC, Jones C, Koh DM, Pearson AD, Chesler L, Robinson SP. Jamin Y, et al. Radiology. 2013 Jan;266(1):130-40. doi: 10.1148/radiol.12120128. Epub 2012 Nov 20. Radiology. 2013. PMID: 23169794 Free PMC article.
PURPOSE: To evaluate noninvasive and clinically translatable magnetic resonance (MR) imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of aggressive, MYCN-amplified neuroblastoma. ...Multiparametric MR imaging was perform …
PURPOSE: To evaluate noninvasive and clinically translatable magnetic resonance (MR) imaging biomarkers of therapeutic …
Feedback